Your HR News Source for Insights & Trends Stay Ahead with TrendTales Navigate HR Trends with TrendTales Unlock HR Insights with TrendTales Discover HR's Evolution with TrendTales
Your HR News Source for Insights & Trends Stay Ahead with TrendTales Navigate HR Trends with TrendTales Unlock HR Insights with TrendTales Discover HR's Evolution with TrendTales

Obesity drugmaker BioAge targets $158 million in IPO

The company is offering 7.5 million shares for $17 to $19 apiece, according to a filing Wednesday. Read More

​The company is offering 7.5 million shares for $17 to $19 apiece, according to a filing Wednesday. Fortune | FORTUNE

Leave a Reply

Your email address will not be published. Required fields are marked *